ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction-Reference-Cited by-同舟云学术

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

Published:1992-03 Issue:8796 Volume:339 Page:753-770
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference61 articles.

1. Coronary thrombolysis;Cairns;Chest,1989

2. Update from the Thrombolysis in Myocardial Infarction Trial;Braunwald;J Am Coll Cardiol,1987

3. Principles and practice of coronary thrombolysis and conjunctive treatment;Sobel;Am J Cardiol,1991

4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;ISIS-2 (Second International Study of Infarct Survival) Collaborative Group;Lancet,1988

5. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects;Patrignani;J Clin Invest,1982

Cited by 833 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consistent covariances estimation for stratum imbalances under minimization method for covariate‐adaptive randomization;Scandinavian Journal of Statistics;2024-01-10

2. Intervention Trials;Handbook of Epidemiology;2023-11-21

3. Minimization in randomized clinical trials;Statistics in Medicine;2023-10-23

4. A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries;Cureus;2023-08-25

5. Acute Coronary Syndromes;Cardiology Board Review;2023-03-10